<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>CORTISPORIN - neomycin sulfate, polymyxin b sulfate and hydrocortisone acetate cream </strong><br>Physicians Total Care, Inc.<br></p></div>
<h1></h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-1"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">CORTISPORIN Cream (neomycin and polymyxin B sulfates and 
hydrocortisone acetate cream, USP) is a topical antibacterial cream. Each gram 
contains: neomycin sulfate equivalent to 3.5 mg neomycin base, polymyxin B 
sulfate equivalent to 10,000 polymyxin B units, and hydrocortisone acetate 5 mg 
(0.5%). The inactive ingredients are liquid petrolatum, white petrolatum, 
propylene glycol, polyoxyethylene polyoxypropylene compound, emulsifying wax, 
purified water, and 0.25% methylparaben added as a preservative. Sodium 
hydroxide or sulfuric acid may be added to adjust pH.</p>
<p>Neomycin sulfate is the sulfate salt of neomycin B and C, which are produced 
by the growth of <span class="Italics">Streptomyces fradiae</span> Waksman (Fam. 
Streptomycetaceae). It has a potency equivalent of not less than 600µg of 
neomycin standard per mg, calculated on an anhydrous basis. The structural 
formulae are:</p>
<p><img alt="image of neomycin sulfate formula" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=e86a5293-312d-4425-bf95-35e4d7149aed&amp;name=cs1.jpg"></p>
<p>Polymyxin B sulfate is the sulfate salt of polymyxin B<span class="Sub">1</span> and B<span class="Sub">2</span>, which are produced by the 
growth of <span class="Italics">Bacillus polymyxa</span> (Prazmowski) Migula (Fam. 
Bacillaceae). It has a potency of not less than 6,000 polymyxin B units per mg, 
calculated on an anhydrous basis. The structural formulae are:</p>
<p><img alt="image of polymyxin b sulfate formula" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=e86a5293-312d-4425-bf95-35e4d7149aed&amp;name=cs2.jpg"></p>
<p>Hydrocortisone acetate is the acetate ester of hydrocortisone, an 
anti-inflammatory hormone. Its chemical name is 21-(acetyloxy)- 
11β,17-dihydroxypregn-4-ene-3,20-dione. Its structural formula is:</p>
<p><img alt="image of hydrocortisone acetate formula" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=e86a5293-312d-4425-bf95-35e4d7149aed&amp;name=cs3.jpg"></p>
<p>The base is a smooth vanishing cream with a pH of approximately 5.0.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-2"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">Corticoids suppress the inflammatory response to a variety of 
agents and they may delay healing. Since corticoids may inhibit the body’s 
defense mechanism against <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span>, a concomitant antimicrobial drug may be 
used when this inhibition is considered to be clinically significant in a 
particular case.</p>
<p>The anti-infective components in the combination are included to provide 
action against specific organisms susceptible to them. Polymyxin B sulfate and 
neomycin sulfate together are considered active against the following 
microorganisms: <span class="Italics">Staphylococcus aureus, Escherichia coli, 
Haemophilus influenzae, Klebsiella- Enterobacter </span>species, <span class="Italics">Neisseria</span> species, and<span class="Italics"> Pseudomonas 
aeruginosa</span>. The product does not provide adequate coverage against <span class="Italics">Serratia marcescens</span> and streptococci, including <span class="Italics">Streptococcus pneumoniae</span>.</p>
<p>The relative potency of corticosteroids depends on the molecular structure, 
concentration, and release from the vehicle.</p>
<p>The acid pH helps restore normal cutaneous acidity. Owing to its excellent 
spreading and penetrating properties, the cream facilitates treatment of hairy 
and intertriginous areas. It may also be of value in selective cases where the 
lesions are moist.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-3"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">For the treatment of corticosteroid-responsive dermatoses with 
<span class="product-label-link" type="condition" conceptid="442777" conceptname="Generalized infection during labor">secondary infection</span>. It has not been demonstrated that this steroid-antibiotic 
combination provides greater benefit than the steroid component alone after 7 
days of treatment (see <a href="#section-6">WARNINGS</a>).</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-4"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">Not for use in the eyes or in the external ear canal if the 
eardrum is perforated. This product is contraindicated in tuberculous, fungal, 
or viral lesions of the skin (herpes simplex, <span class="product-label-link" type="condition" conceptid="140633" conceptname="Vaccinia">vaccinia</span>, and <span class="product-label-link" type="condition" conceptid="434272" conceptname="Varicella">varicella</span>). This 
product is contraindicated in those individuals who have shown <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> 
to any of its components.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="section-5"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">Because of the concern of <span class="product-label-link" type="condition" conceptid="4126119" conceptname="Toxic nephropathy">nephrotoxicity</span> and <span class="product-label-link" type="condition" conceptid="4236623" conceptname="Ototoxicity">ototoxicity</span> 
associated with neomycin, this combination should not be used over a wide area 
or for extended periods of time.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="section-6"></a><p></p>
<h1>PRECAUTIONS</h1>
<a href="#section-"></a><a href="http://"></a><span>General</span><p class="First">As with any antibacterial preparation, prolonged use may result 
in overgrowth of nonsusceptible organisms, including fungi. Appropriate measures 
should be taken if this occurs. Use of steroids on infected areas should be 
supervised with care as anti-inflammatory steroids may encourage spread of 
<span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span>. If this occurs, steroid therapy should be stopped and appropriate 
anti-bacterial drugs used. Generalized dermatological conditions may require 
systemic corticosteroid therapy.</p>
<p>Signs and symptoms of exogenous <span class="product-label-link" type="condition" conceptid="438123" conceptname="Adrenocortical hyperfunction">hyperadrenocorticism</span> can occur with the use 
of topical corticosteroids, including adrenal suppression. Systemic absorption 
of topically applied steroids will be increased if extensive body surface areas 
are treated or if occlusive dressings are used. Under these circumstances, 
suitable precautions should be taken when long-term use is anticipated.</p>
<p>Specifically, sufficient percutaneous absorption of hydrocortisone can occur 
in pediatric patients during prolonged use to cause cessation of growth, as well 
as other systemic signs and symptoms of <span class="product-label-link" type="condition" conceptid="438123" conceptname="Adrenocortical hyperfunction">hyperadrenocorticism</span>.</p>
<a href="http://"></a><a href="http://"></a>Information for Patients<p>If <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">redness</span>, irritation, <span class="product-label-link" type="condition" conceptid="4275722" conceptname="Swelling">swelling</span> or <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span> persists or increases, 
discontinue use and notify physician. Do not use in the eyes.</p>
<a href="http://"></a><a href="http://"></a>Laboratory Tests<p>Systemic effects of excessive levels of hydrocortisone may 
include a reduction in the number of circulating eosinophils and a decrease in 
urinary excretion of 17-hydroxycorticosteroids.</p>
<a href="http://"></a><a href="http://"></a>Carcinogenesis, Mutagenesis, Impairment of 
Fertility<p>Longterm studies in animals (rats, rabbits, mice) showed no 
evidence of carcinogenicity attributable to oral administration of 
corticosteroids.</p>
<a href="http://"></a><a href="http://"></a>Pregnancy<a href="http://"></a><a href="http://"></a><span class="Bold"><span class="Italics">Teratogenic 
Effects</span></span><p>Pregnancy Category C. Corticosteroids have been shown to be 
teratogenic in rabbits when applied topically at concentrations of 0.5% on days 
6 to 18 of gestation and in mice when applied topically at a concentration of 
15% on days 10 to 13 of gestation. There are no adequate and well-controlled 
studies in pregnant women. Corticosteroids should be used during pregnancy only 
if the potential benefit justifies the potential risk to the fetus.</p>
<a href="http://"></a><a href="http://"></a>Nursing Mothers<p>Hydrocortisone acetate appears in human milk following oral 
administration of the drug. Since systemic absorption of hydrocortisone may 
occur when applied topically, caution should be exercised when CORTISPORIN Cream 
is used by a nursing woman.</p>
<a href="http://"></a><a href="http://"></a>Geriatric Use<p>Clinical studies of Cortisporin Cream did not include sufficient 
numbers of subjects aged 65 and over to determine whether they respond 
differently from younger subjects. Other reported clinical experience has not 
identified differences in responses between the elderly and younger patients. In 
general, dose selection for an elderly patient should be cautious, usually 
starting at the low end of the dosing range, reflecting the greater frequency of 
decreased hepatic, renal, or cardiac function, and of concomitant disease or 
other drug therapy.</p>
<a href="http://"></a><a href="http://"></a>Pediatric Use<p>Safety and effectiveness in pediatric patients have not been 
established (see <a href="#section-7.1">PRECAUTIONS: General</a>).</p>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-7"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">Neomycin occasionally causes skin sensitization. <span class="product-label-link" type="condition" conceptid="4236623" conceptname="Ototoxicity">Ototoxicity</span> and 
<span class="product-label-link" type="condition" conceptid="4126119" conceptname="Toxic nephropathy">nephrotoxicity</span> have also been reported (see <a href="#section-6">WARNINGS</a>). 
Adverse reactions have occurred with topical use of antibiotic combinations 
including neomycin and polymyxin B. Exact incidence figures are not available 
since no denominator of treated patients is available. The reaction occurring 
most often is allergic sensitization. In one clinical study, using a 20% 
neomycin patch, neomycin-induced <span class="product-label-link" type="condition" conceptid="4070025" conceptname="Cutaneous hypersensitivity">allergic skin reactions</span> occurred in two of 
2,175 (0.09%) individuals in the general population.<span class="Sup">1</span> In 
another study, the incidence was found to be approximately 1%.<span class="Sup">2</span></p>
<p>The following local adverse reactions have been reported with topical 
corticosteroids, especially under occlusive dressings: burning, <span class="product-label-link" type="condition" conceptid="4302654" conceptname="Itching">itching</span>, 
irritation, dryness, <span class="product-label-link" type="condition" conceptid="4029295" conceptname="Folliculitis">folliculitis</span>, <span class="product-label-link" type="condition" conceptid="443793" conceptname="Hypertrichosis">hypertrichosis</span>, <span class="product-label-link" type="condition" conceptid="4299558" conceptname="Acneiform eruption">acneiform eruptions</span>, 
hypopigmentation, <span class="product-label-link" type="condition" conceptid="135032" conceptname="Dermatitis due to substances taken internally">perioral dermatitis</span>, <span class="product-label-link" type="condition" conceptid="134438" conceptname="Contact dermatitis">allergic contact dermatitis</span>, maceration 
of the skin, <span class="product-label-link" type="condition" conceptid="442777" conceptname="Generalized infection during labor">secondary infection</span>, <span class="product-label-link" type="condition" conceptid="134118" conceptname="Atrophic condition of skin">skin atrophy</span>, <span class="product-label-link" type="condition" conceptid="137054" conceptname="Skin striae">striae</span>, and <span class="product-label-link" type="condition" conceptid="4273714" conceptname="Miliaria">miliaria</span>.</p>
<p>When steroid preparations are used for long periods of time in intertriginous 
areas or over extensive body areas, with or without occlusive non-permeable 
dressings, <span class="product-label-link" type="condition" conceptid="137054" conceptname="Skin striae">striae</span> may occur; also there exists the possibility of systemic side 
effects when steroid preparations are used over large areas or for a long period 
of time.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-8"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">A small quantity of the cream should be applied 2 to 4 times 
daily, as required. The cream should, if conditions permit, be gently rubbed 
into the affected areas.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-9"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">Tube of 7.5 g   (NDC 54868-1531-1). </p>
<p><span class="Bold"><br></span></p>
<p><span class="Bold">Store at 15° to 25°C (59° to 77°F).</span></p>
<a href="http://"></a><a href="http://"></a><br>References<ol>
<li><p class="First">Leyden JJ, Kligman AM. <span class="product-label-link" type="condition" conceptid="134438" conceptname="Contact dermatitis">Contact dermatitis</span> to neomycin sulfate. 
<span class="Italics">JAMA</span>. 1979;242:1276-1278.</p></li>
<li><p class="First">Prystowsky SD, Allen AM, Smith RW, et al. Allergic contact 
<span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to nickel, neomycin, ethylenediamine, and benzocaine. <span class="Italics">Arch Dermatol</span>. 1979;115:959-962.</p></li>
</ol>
<p>Prescribing Information as of November 2003. </p>
<p><br></p>
<p>Distributed by: Monarch Pharmaceuticals, Inc., Bristol, TN 37620 </p>
<p>(A wholly owned subsidiary of King Pharmaceuticals, Inc.) </p>
<p>Manufactured by: King Pharmaceuticals, Inc., Bristol, TN 37620</p>
<br><p><br></p>
<p><span class="Bold">Relabeling of "Additional Barcode" label by:</span><br>Physicians Total Care, Inc.<br>Tulsa, OK       74146<br></p>
<br>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-10"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL</h1>
<p class="First">CORTISPORIN Cream (neomycin and polymyxin B sulfates and hydrocortisone acetate 
cream, USP)</p>
<p><img alt="image of package label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=e86a5293-312d-4425-bf95-35e4d7149aed&amp;name=1531.jpg"></p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>CORTISPORIN 		
					</strong><br><span class="contentTableReg">neomycin sulfate, polymyxin b sulfate and hydrocortisone acetate cream</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:54868-1531(NDC:61570-032-75)</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">TOPICAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>NEOMYCIN SULFATE</strong> (NEOMYCIN) </td>
<td class="formItem">NEOMYCIN SULFATE</td>
<td class="formItem">3.5 mg  in 1 g</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>POLYMYXIN B SULFATE</strong> (POLYMYXIN B) </td>
<td class="formItem">POLYMYXIN B SULFATE</td>
<td class="formItem">10000 U  in 1 g</td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>HYDROCORTISONE ACETATE</strong> (HYDROCORTISONE) </td>
<td class="formItem">HYDROCORTISONE ACETATE</td>
<td class="formItem">5 mg  in 1 g</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>LIGHT MINERAL OIL</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>PETROLATUM</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>METHYLPARABEN</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>PROPYLENE GLYCOL</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:54868-1531-1</td>
<td class="formItem">1  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">7.5 g in 1 TUBE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA050218</td>
<td class="formItem">07/19/1994</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Physicians Total Care, Inc.
							(194123980)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Physicians Total Care, Inc.</td>
<td class="formItem"></td>
<td class="formItem">194123980</td>
<td class="formItem">relabel</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 12/2010<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>68c1b49b-a16c-40a9-9b5e-76df9e8d19e2</div>
<div>Set id: e86a5293-312d-4425-bf95-35e4d7149aed</div>
<div>Version: 1</div>
<div>Effective Time: 20101230</div>
</div>
</div> <div class="DistributorName">Physicians Total Care, Inc.</div></p>
</body></html>
